LivaNova initiated with an Overweight at Barclays
Clear upside from target upgrade.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Clear upside from target upgrade.
What happened, with direct paths to the underlying reporting
Barclays initiates LivaNova with an Overweight rating; target price $105 vs. current price $74.93.
Target: $105
Posted price: $74.93
Analyst firm: Barclays
Analyst: Christopher Pasquale
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.